Israel Englander Merrimack Pharmaceuticals Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

Shares

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 14, 2023	SELL	$12.02 - $13.07 $354,049 - $384,976	-29,455 Reduced 73.26%	10,749 $132,000
Q1 2023 May 15, 2023	BUY	$11.35 - $12.32 $263,535 - $286,058	23,219 Added 136.7%	40,204 $494,000
Q4 2022 Feb 14, 2023	BUY	$3.68 - $12.51 $62,504 - $212,482	16,985 New	16,985 $195,000
Q3 2021 Nov 15, 2021	SELL	$4.3 - $6.39 $48,104 - $71,484	-11,187 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.04 - $7.77 $6,674 - $8,585	-1,105 Reduced 8.99%	11,187 $71,000
Q1 2021 May 17, 2021	BUY	$6.15 - $8.7 $75,595 - $106,940	12,292 New	12,292 $77,000
Q2 2019 Aug 14, 2019	SELL	$4.39 - $5.66 $46,108 - $59,446	-10,503 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$3.19 - $5.73 $56,402 - $101,312	-17,681 Reduced 62.73%	10,503 $73,000
Q4 2018 Feb 14, 2019	SELL	$2.95 - $4.15 $311,124 - $437,683	-105,466 Reduced 78.91%	28,184 $109,000
Q3 2018 Nov 14, 2018	SELL	$3.91 - $4.66 $145,670 - $173,612	-37,256 Reduced 21.8%	133,650 $712,000
Q2 2018 Aug 14, 2018	BUY	$3.86 - $7.61 $152,091 - $299,849	39,402 Added 29.96%	170,906 $839,000
Q1 2018 May 15, 2018	SELL	$6.24 - $9.15 $455,906 - $668,517	-73,062 Reduced 35.72%	131,504 $1.06 Million
Q4 2017 Feb 14, 2018	BUY	$7.99 - $11.87 $1.12 Million - $1.67 Million	140,567 Added 219.64%	204,566 $2.1 Million
Q3 2017 Nov 14, 2017	BUY	$9.13 - $11.72 $584,310 - $750,068	63,999	63,999 $931,000

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.